Cargando…

Serum anti-phospholipase A2 receptor antibody in pathological diagnosis of type 2 diabetes mellitus patients with proteinuria

Patients with diabetes mellitus complicated with proteinuria can be diabetic nephropathy (DN), diabetic complicated with non-diabetic kidney disease (NDKD), or DN with NDKD. Among these membranous nephropathy accounted for a large proportion of DN with NDRD. At present, serum anti-phospholipase A2 r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Huanhuan, Zhu, Yuanjie, Hu, Zhijuan, Liu, Qiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547755/ https://www.ncbi.nlm.nih.gov/pubmed/37789020 http://dx.doi.org/10.1038/s41598-023-43766-8

Ejemplares similares

Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy
por: Dong, Lei, et al.
Publicado: (2022)

Phospholipase‐A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy
por: Xiao, Chunying, et al.
Publicado: (2020)

Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy
por: Barrett, Christine, et al.
Publicado: (2020)

Role of Anti-Phospholipase A(2) Receptor Antibodies in the Differential Diagnosis of Diabetic and Membranous Nephropathy
por: Pocivalnik, Mirjam, et al.
Publicado: (2013)

Anti-phospholipase A2 receptor antibodies in membranous nephropathy
por: Lee, Sangho
Publicado: (2018)

Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study
por: Yin, Peihong, et al.
Publicado: (2020)

Monitoring for proteinuria in patients with type 2 diabetes mellitus
por: Liang, Huifang, et al.
Publicado: (2015)

Anti-phospholipase A2 receptor antibody and spontaneous remission in membranous nephropathy
por: Diaz, Montserrat, et al.
Publicado: (2018)

Anti-phospholipase A2 Receptor Antibody-Negative Membranous Nephropathy in Pregnancy
por: Saleem, Maryam, et al.
Publicado: (2023)

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy
por: Jullien, Perrine, et al.
Publicado: (2017)

Current concepts on anti-Phospholipase A2 receptor antibody in Idiopathic membranous nephropathy
por: Ardalan, Mohammad Reza
Publicado: (2013)

Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy
por: Akiyama, Shin’ichi, et al.
Publicado: (2014)

Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: New concepts
por: Ardalan, Mohammad-Reza, et al.
Publicado: (2013)

Anti-phospholipase A2 receptor antibodies directly induced podocyte damage in vitro
por: Li, Yanfen, et al.
Publicado: (2022)

Serum anti-phospholipase A2 receptor (PLA2R) antibody detected at diagnosis as a predictor for clinical remission in patients with primary membranous nephropathy: a meta-analysis
por: Liang, Yufeng, et al.
Publicado: (2019)

Anti-Phospholipase A2 Receptor Antibody Expression at Different Stages of Idiopathic Membranous Nephropathy
por: Fu, Keying, et al.
Publicado: (2022)

Prevalence of serum anti M-type phospholipase A(2) receptor antibody in primary membranous nephropathy: A single center experience
por: Gopalakrishnan, N., et al.
Publicado: (2016)

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients
por: Wang, Bihua, et al.
Publicado: (2022)

Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China
por: Guo, Naifeng, et al.
Publicado: (2019)

Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria
por: Xu, Peng-Cheng, et al.
Publicado: (2018)

Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy
por: Surindran, Sheena, et al.
Publicado: (2012)

Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy
por: Song, Eun Joo, et al.
Publicado: (2018)

Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2020)

Correction: Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients
por: Wang, Bihua, et al.
Publicado: (2022)

Association of serum uric acid with proteinuria in type 2 diabetic patients
por: Behradmanesh, Saeed, et al.
Publicado: (2013)

Preparation of an epitope-based recombinant diagnostic antigen specific to anti-phospholipase A(2) receptor 1 antibodies
por: Li, Hua, et al.
Publicado: (2018)

Analysis of predictive factors for immunosuppressive response in anti-phospholipase A2 receptor antibody positive membranous nephropathy
por: Li, Chao, et al.
Publicado: (2018)

A case report of breast cancer and membranous nephropathy with positive anti phospholipase A2 receptor antibodies
por: Mathew, David, et al.
Publicado: (2021)

Association of the clinicopathological characteristics and proteinuria remission of pediatric IgAV with nephrotic-range proteinuria: A retrospective cohort study
por: Kang, Zhijuan, et al.
Publicado: (2022)

Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience
por: Porcelli, Brunetta, et al.
Publicado: (2020)

Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous Nephropathy
por: Vink, Coralien H., et al.
Publicado: (2022)

Role of phospholipase A(2) receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy
por: Mahmud, Maida, et al.
Publicado: (2019)

Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy
por: Zhang, Qiuhua, et al.
Publicado: (2017)

Ischemic stroke in anti-phospholipase A2 receptor antibody-positive primary membranous nephropathy: clinical and neuroimaging characteristics
por: Zhang, Jing, et al.
Publicado: (2020)

Retrospective study: clinicopathological features and prognosis of idiopathic membranous nephropathy with seronegative anti-phospholipase A2 receptor antibody
por: Guo, Wenkai, et al.
Publicado: (2020)

Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy
por: Stefan, Gabriel, et al.
Publicado: (2022)

Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy
por: Hihara, Kei, et al.
Publicado: (2016)

Anti-Phospholipase A2 Receptor in Nonlupus Patients with Membranous Nephropathy and Crescents
por: Zuo, Yiqin, et al.
Publicado: (2021)

IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor
por: Khosroshahi, Arezou, et al.
Publicado: (2012)

Immunohistochemical Analysis of Anti-phospholipase A2 Receptor Antibody on Renal Biopsies: A Single Tertiary Care Center Study
por: Gudipati, A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_te1n8ac21rhml1oof6ub82ab1b